Annual CFI
-$50.65 M
-$30.64 M-153.09%
31 December 2023
Summary:
TG Therapeutics annual cash flow from investing activities is currently -$50.65 million, with the most recent change of -$30.64 million (-153.09%) on 31 December 2023. During the last 3 years, it has fallen by -$26.14 million (-106.65%). TGTX annual CFI is now -290.81% below its all-time high of $26.55 million, reached on 31 December 2016.TGTX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$9.33 M
-$11.10 M-628.84%
30 September 2024
Summary:
TG Therapeutics quarterly cash flow from investing activities is currently -$9.33 million, with the most recent change of -$11.10 million (-628.84%) on 30 September 2024. Over the past year, it has increased by +$20.89 million (+69.12%). TGTX quarterly CFI is now -130.60% below its all-time high of $30.50 million, reached on 30 June 2023.TGTX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$61.58 M
+$20.89 M+25.34%
30 September 2024
Summary:
TG Therapeutics TTM cash flow from investing activities is currently -$61.58 million, with the most recent change of +$20.89 million (+25.34%) on 30 September 2024. Over the past year, it has dropped by -$71.95 million (-693.65%). TGTX TTM CFI is now -261.82% below its all-time high of $38.05 million, reached on 30 June 2017.TGTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TGTX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -153.1% | +69.1% | -693.6% |
| 3 y3 years | -106.7% | -1379.2% | -10.6% |
| 5 y5 years | -4392.5% | -10000.0% | -10000.0% |
TGTX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -130.6% | +79.1% | -263.7% | +25.3% |
| 5 y | 5 years | -4392.5% | at low | -130.6% | +82.1% | -263.7% | +25.3% |
| alltime | all time | -290.8% | at low | -130.6% | +82.1% | -261.8% | +25.3% |
TG Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.33 M(-628.8%) | -$61.58 M(-25.3%) |
| June 2024 | - | $1.76 M(-119.1%) | -$82.47 M(+53.5%) |
| Mar 2024 | - | -$9.26 M(-79.3%) | -$53.74 M(+6.1%) |
| Dec 2023 | -$50.65 M(+153.1%) | -$44.76 M(+48.1%) | -$50.65 M(-588.3%) |
| Sept 2023 | - | -$30.23 M(-199.1%) | $10.37 M(-72.4%) |
| June 2023 | - | $30.50 M(-594.5%) | $37.61 M(+115.0%) |
| Mar 2023 | - | -$6.17 M(-137.9%) | $17.49 M(-187.4%) |
| Dec 2022 | -$20.01 M(+5928.0%) | $16.27 M(-644.1%) | -$20.01 M(-39.3%) |
| Sept 2022 | - | -$2.99 M(-128.8%) | -$32.99 M(+7.7%) |
| June 2022 | - | $10.38 M(-123.8%) | -$30.64 M(-29.6%) |
| Mar 2022 | - | -$43.67 M(-1428.2%) | -$43.49 M(>+9900.0%) |
| Dec 2021 | -$332.00 K(-98.6%) | $3.29 M(-621.1%) | -$332.00 K(-99.4%) |
| Sept 2021 | - | -$631.00 K(-74.5%) | -$55.70 M(+38.7%) |
| June 2021 | - | -$2.48 M(+381.5%) | -$40.15 M(+51.7%) |
| Mar 2021 | - | -$514.00 K(-99.0%) | -$26.47 M(+8.0%) |
| Dec 2020 | -$24.51 M(+3313.6%) | -$52.08 M(-449.2%) | -$24.51 M(-188.9%) |
| Sept 2020 | - | $14.91 M(+33.1%) | $27.57 M(+118.5%) |
| June 2020 | - | $11.21 M(+672.8%) | $12.62 M(+575.7%) |
| Mar 2020 | - | $1.45 M(>+9900.0%) | $1.87 M(-360.0%) |
| Dec 2019 | -$718.00 K(-160.8%) | $4000.00(-109.1%) | -$718.00 K(+48.3%) |
| Sept 2019 | - | -$44.00 K(-109.6%) | -$484.00 K(-93.0%) |
| June 2019 | - | $457.00 K(-140.3%) | -$6.88 M(+293.5%) |
| Mar 2019 | - | -$1.14 M(-576.9%) | -$1.75 M(-248.1%) |
| Dec 2018 | $1.18 M(-114.4%) | $238.00 K(-103.7%) | $1.18 M(-104.4%) |
| Sept 2018 | - | -$6.43 M(-215.2%) | -$27.06 M(+128.8%) |
| June 2018 | - | $5.58 M(+211.7%) | -$11.83 M(-4.7%) |
| Mar 2018 | - | $1.79 M(-106.4%) | -$12.42 M(+51.3%) |
| Dec 2017 | -$8.21 M(-130.9%) | -$28.01 M(-418.3%) | -$8.21 M(-126.2%) |
| Sept 2017 | - | $8.80 M(+76.1%) | $31.28 M(-17.8%) |
| June 2017 | - | $5.00 M(-16.7%) | $38.05 M(+10.4%) |
| Mar 2017 | - | $6.00 M(-47.7%) | $34.47 M(+29.8%) |
| Dec 2016 | $26.55 M(-207.5%) | $11.48 M(-26.3%) | $26.55 M(+51.3%) |
| Sept 2016 | - | $15.58 M(+1001.9%) | $17.54 M(+757.9%) |
| June 2016 | - | $1.41 M(-173.5%) | $2.05 M(-106.7%) |
| Mar 2016 | - | -$1.92 M(-177.6%) | -$30.45 M(+23.4%) |
| Dec 2015 | -$24.69 M(+34.5%) | $2.48 M(+3135.6%) | -$24.69 M(-32.0%) |
| Sept 2015 | - | $76.60 K(-100.2%) | -$36.30 M(-0.2%) |
| June 2015 | - | -$31.08 M(-908.8%) | -$36.38 M(+150.7%) |
| Mar 2015 | - | $3.84 M(-142.1%) | -$14.51 M(-21.0%) |
| Dec 2014 | -$18.36 M(+272.7%) | -$9.13 M(>+9900.0%) | -$18.36 M(+29.8%) |
| Sept 2014 | - | -$1300.00(-100.0%) | -$14.14 M(-0.0%) |
| June 2014 | - | -$9.22 M(>+9900.0%) | -$14.15 M(+187.0%) |
| Mar 2014 | - | -$3200.00(-99.9%) | -$4.93 M(+0.1%) |
| Dec 2013 | -$4.93 M(>+9900.0%) | -$4.92 M(>+9900.0%) | -$4.93 M(>+9900.0%) |
| Sept 2013 | - | -$1600.00(-5.9%) | -$3300.00(+94.1%) |
| June 2013 | - | -$1700.00(<-9900.0%) | -$1700.00(+21.4%) |
| Mar 2013 | - | $0.00(0.0%) | -$1400.00(0.0%) |
| Dec 2012 | -$1400.00(-113.5%) | $0.00(0.0%) | -$1400.00(-115.6%) |
| Sept 2012 | - | $0.00(-100.0%) | $9000.00(0.0%) |
| June 2012 | - | -$1400.00(<-9900.0%) | $9000.00(>+9900.0%) |
| Mar 2012 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2011 | $10.40 K(-98.0%) | $10.40 K(>+9900.0%) | $10.40 K(>+9900.0%) |
| Sept 2011 | - | $0.00(-100.0%) | $0.00(0.0%) |
| June 2011 | - | -$10.40 K(-200.0%) | $0.00(-100.0%) |
| Mar 2011 | - | $10.40 K(>+9900.0%) | $7600.00(-98.5%) |
| Dec 2010 | $516.50 K | $0.00(0.0%) | $516.60 K(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2010 | - | $0.00(-100.0%) | $516.60 K(0.0%) |
| June 2010 | - | -$2800.00(-100.5%) | $516.60 K(-0.5%) |
| Mar 2010 | - | $519.40 K(>+9900.0%) | $519.40 K(>+9900.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2009 | - | $0.00(0.0%) | $13.60 K(+195.7%) |
| Mar 2009 | - | $0.00(0.0%) | $4600.00(-151.1%) |
| Dec 2008 | -$9000.00(-1.1%) | $0.00(-100.0%) | -$9000.00(0.0%) |
| Sept 2008 | - | $13.60 K(-251.1%) | -$9000.00(-60.2%) |
| June 2008 | - | -$9000.00(-33.8%) | -$22.60 K(+37.0%) |
| Mar 2008 | - | -$13.60 K(<-9900.0%) | -$16.50 K(+79.3%) |
| Dec 2007 | -$9100.00(-100.9%) | $0.00(0.0%) | -$9200.00(-101.9%) |
| Sept 2007 | - | $0.00(-100.0%) | $475.40 K(+0.6%) |
| June 2007 | - | -$2900.00(-54.0%) | $472.40 K(+0.3%) |
| Mar 2007 | - | -$6300.00(-101.3%) | $471.00 K(-51.4%) |
| Dec 2006 | $968.80 K(-72.1%) | $484.60 K(<-9900.0%) | $968.80 K(+104.5%) |
| Sept 2006 | - | -$3000.00(-30.2%) | $473.70 K(-51.4%) |
| June 2006 | - | -$4300.00(-100.9%) | $974.70 K(-68.7%) |
| Mar 2006 | - | $491.50 K(-4781.0%) | $3.11 M(-10.3%) |
| Dec 2005 | $3.47 M(-182.4%) | -$10.50 K(-102.1%) | $3.47 M(-436.6%) |
| Sept 2005 | - | $498.00 K(-76.6%) | -$1.03 M(-35.8%) |
| June 2005 | - | $2.13 M(+151.1%) | -$1.61 M(-51.7%) |
| Mar 2005 | - | $848.80 K(-118.8%) | -$3.33 M(-21.0%) |
| Dec 2004 | -$4.21 M(-2720.3%) | -$4.51 M(+5731.8%) | -$4.21 M(-1503.7%) |
| Sept 2004 | - | -$77.30 K(-118.8%) | $299.80 K(-47.9%) |
| June 2004 | - | $411.10 K(-1309.1%) | $575.60 K(+249.9%) |
| Mar 2004 | - | -$34.00 K(<-9900.0%) | $164.50 K(+2.4%) |
| Dec 2003 | $160.60 K(>+9900.0%) | $0.00(-100.0%) | $160.60 K(-1.7%) |
| Sept 2003 | - | $198.50 K(>+9900.0%) | $163.30 K(-530.9%) |
| June 2003 | - | $0.00(-100.0%) | -$37.90 K(0.0%) |
| Mar 2003 | - | -$37.90 K(-1503.7%) | -$37.90 K(<-9900.0%) |
| Dec 2002 | $0.00(-100.0%) | $2700.00(-200.0%) | $0.00(-100.0%) |
| Sept 2002 | - | -$2700.00(<-9900.0%) | -$2700.00(-57.8%) |
| June 2002 | - | $0.00(0.0%) | -$6400.00(-70.4%) |
| Mar 2002 | - | $0.00(0.0%) | -$21.60 K(-100.7%) |
| Dec 2001 | $2.89 M(-1009.4%) | $0.00(-100.0%) | $2.89 M(+1.2%) |
| Sept 2001 | - | -$6400.00(-57.9%) | $2.86 M(+5.3%) |
| June 2001 | - | -$15.20 K(-100.5%) | $2.71 M(-4.8%) |
| Mar 2001 | - | $2.91 M(-8796.4%) | $2.85 M(-997.0%) |
| Dec 2000 | -$318.00 K(+218.0%) | -$33.50 K(-77.9%) | -$317.90 K(-17.3%) |
| Sept 2000 | - | -$151.30 K(-223.0%) | -$384.40 K(+64.9%) |
| June 2000 | - | $123.00 K(-148.0%) | -$233.10 K(-34.5%) |
| Mar 2000 | - | -$256.10 K(+156.1%) | -$356.10 K(+256.1%) |
| Dec 1999 | -$100.00 K(-50.0%) | -$100.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) |
| Sept 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 1999 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 1999 | - | $0.00(0.0%) | -$100.00 K(-50.0%) |
| Dec 1998 | -$200.00 K(0.0%) | $0.00(0.0%) | -$200.00 K(0.0%) |
| Sept 1998 | - | $0.00(-100.0%) | -$200.00 K(-33.3%) |
| June 1998 | - | -$100.00 K(0.0%) | -$300.00 K(0.0%) |
| Mar 1998 | - | -$100.00 K(<-9900.0%) | -$300.00 K(+50.0%) |
| Dec 1997 | -$200.00 K(+100.0%) | $0.00(-100.0%) | -$200.00 K(0.0%) |
| Sept 1997 | - | -$100.00 K(0.0%) | -$200.00 K(+100.0%) |
| June 1997 | - | -$100.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) |
| Mar 1997 | - | $0.00 | $0.00 |
| Dec 1996 | -$100.00 K | - | - |
FAQ
- What is TG Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for TG Therapeutics?
- What is TG Therapeutics annual CFI year-on-year change?
- What is TG Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for TG Therapeutics?
- What is TG Therapeutics quarterly CFI year-on-year change?
- What is TG Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for TG Therapeutics?
- What is TG Therapeutics TTM CFI year-on-year change?
What is TG Therapeutics annual cash flow from investing activities?
The current annual CFI of TGTX is -$50.65 M
What is the all time high annual CFI for TG Therapeutics?
TG Therapeutics all-time high annual cash flow from investing activities is $26.55 M
What is TG Therapeutics annual CFI year-on-year change?
Over the past year, TGTX annual cash flow from investing activities has changed by -$30.64 M (-153.09%)
What is TG Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TGTX is -$9.33 M
What is the all time high quarterly CFI for TG Therapeutics?
TG Therapeutics all-time high quarterly cash flow from investing activities is $30.50 M
What is TG Therapeutics quarterly CFI year-on-year change?
Over the past year, TGTX quarterly cash flow from investing activities has changed by +$20.89 M (+69.12%)
What is TG Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TGTX is -$61.58 M
What is the all time high TTM CFI for TG Therapeutics?
TG Therapeutics all-time high TTM cash flow from investing activities is $38.05 M
What is TG Therapeutics TTM CFI year-on-year change?
Over the past year, TGTX TTM cash flow from investing activities has changed by -$71.95 M (-693.65%)